National Research Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Los beneficios de National Research han disminuido a una tasa media anual de -0.6%, mientras que en la industria Healthcare los beneficios crecieron en un 7.1% anualmente. Los ingresos han ido creciendo a una tasa media de 5% al año. La rentabilidad financiera de National Research es de 63.3%, y sus márgenes netos son de 20.8%.

Información clave

-0.6%

Tasa de crecimiento de los beneficios

0.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	5.0%
Rentabilidad financiera	63.3%
Margen neto	20.8%
Próxima actualización de resultados	08 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Feb 20

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Dec 13

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Oct 01

The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

Mar 21

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Feb 11

National Research (NASDAQ:NRC) Is Achieving High Returns On Its Capital

Nov 25

Is National Research (NASDAQ:NRC) A Risky Investment?

Nov 02

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Jul 15

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero National Research. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGS:NRC Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	149	31	47
30 Sep 23	149	29	46
30 Jun 23	148	29	45
31 Mar 23	150	30	44
31 Dec 22	152	32	43
30 Sep 22	152	35	42
30 Jun 22	152	36	41
31 Mar 22	151	37	40
31 Dec 21	148	37	39
30 Sep 21	144	36	38
30 Jun 21	140	36	36
31 Mar 21	135	35	35
31 Dec 20	133	37	34
30 Sep 20	131	38	34
30 Jun 20	130	36	35
31 Mar 20	130	36	34
31 Dec 19	128	32	33
30 Sep 19	126	31	33
30 Jun 19	124	30	32
31 Mar 19	120	31	31
31 Dec 18	120	30	31
30 Sep 18	119	29	31
30 Jun 18	118	26	32
31 Mar 18	118	24	31
31 Dec 17	118	23	30
30 Sep 17	116	22	29
30 Jun 17	114	23	27
31 Mar 17	112	21	28
31 Dec 16	109	20	28
30 Sep 16	107	21	28
30 Jun 16	106	20	28
31 Mar 16	104	19	27
31 Dec 15	102	17	27
30 Sep 15	101	16	28
30 Jun 15	100	16	27
31 Mar 15	99	16	26
31 Dec 14	99	18	25
30 Sep 14	97	18	24
30 Jun 14	95	17	25
31 Mar 14	94	16	25
31 Dec 13	93	15	25
30 Sep 13	92	15	25
30 Jun 13	91	15	25

Ingresos de calidad: NRC tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(20.8%) de NRC son inferiores a los del año pasado (21%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de NRC han disminuido en un 0.6% al año en los últimos 5 años.

Acelerando crecimiento: NRC ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: NRC tuvo un crecimiento negativo de los beneficios (-2.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (7.3%).

National Research Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

Third quarter 2023 earnings released: EPS: US$0.32 (vs US$0.34 in 3Q 2022)

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

Recent updates

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Upcoming dividend of US$0.12 per share

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Dividend of US$0.12 announced

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

National Research Corporation Announces Executive Appointments

Insider recently sold US$15m worth of stock

Upcoming dividend of US$0.12 per share at 1.2% yield

Founder recently sold US$2.3m worth of stock

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

New minor risk - Insider selling

National Research Corporation Declares Quarterly Dividend, Payable on January 12, 2024

Founder notifies of intention to sell stock

Third quarter 2023 earnings released: EPS: US$0.32 (vs US$0.34 in 3Q 2022)

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Upcoming dividend of US$0.12 per share at 1.0% yield

Upcoming dividend of US$1.00 per share at 1.1% yield

National Research Corporation Declares Special Dividend, Payable on September 22, 2023

National Research Corporation Declares Quarterly Dividend, Payable on October 13, 2023

Second quarter 2023 earnings released: EPS: US$0.30 (vs US$0.33 in 2Q 2022)

National Research Corporation to Report Q2, 2023 Results on Aug 01, 2023

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Upcoming dividend of US$0.12 per share at 1.9% yield

Founder recently sold US$1.5m worth of stock

Founder recently sold US$954k worth of stock

Founder recently sold US$1.3m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on July 14, 2023

Why We Like The Returns At National Research (NASDAQ:NRC)

First quarter 2023 earnings released: EPS: US$0.28 (vs US$0.34 in 1Q 2022)

Founder recently sold US$59k worth of stock

Chief Operating Officer recently sold US$1.1m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Upcoming dividend of US$0.12 per share at 1.9% yield

Senior VP of Finance recently sold US$544k worth of stock

Founder recently sold US$292k worth of stock

Full year 2022 earnings released: EPS: US$1.28 (vs US$1.47 in FY 2021)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 14, 2023

National Research Corporation to Report Q4, 2022 Results on Feb 14, 2023

Founder recently sold US$259k worth of stock

Founder exercised options to buy US$439k worth of stock.

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Declares Quarterly Dividend, Payable on January 13, 2023

Third quarter 2022 earnings released: EPS: US$0.34 (vs US$0.38 in 3Q 2021)

Founder recently sold US$1.8m worth of stock

Founder recently sold US$1.8m worth of stock

Chief Operating Officer exercised options and sold US$339k worth of stock

Upcoming dividend of US$0.24 per share

National Research Corp: Market Is Discounting These Key Factors

Founder recently sold US$3.9m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on October 14, 2022

National Research declares $0.24 dividend

Now 20% undervalued

National Research GAAP EPS of $0.33, revenue of $37.3M

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Upcoming dividend of US$0.24 per share

Founder recently sold US$8.9m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research Corporation Announces Quarterly Dividend, Payable on July 15, 2022

National Research Corporation Announces Appointment to Board of Directors

National Research Corp.: Quality/Low Risk On Sale

First quarter 2022 earnings released: EPS: US$0.34 (vs US$0.36 in 1Q 2021)

Desglose de ingresos y gastos
Beta